|
Volumn 1, Issue 1, 1999, Pages 25-30
|
Treatment of negative and cognitive symptoms.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMETABOLITE;
CYCLOSERINE;
GLYCINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
SERINE;
COGNITIVE DEFECT;
DRUG EFFECT;
HUMAN;
PHYSIOLOGY;
PSYCHOLOGY;
REVIEW;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ANTIMETABOLITES;
ANTIPSYCHOTIC AGENTS;
COGNITION DISORDERS;
CYCLOSERINE;
GLYCINE;
HUMANS;
RECEPTORS, N-METHYL-D-ASPARTATE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SERINE;
TREATMENT OUTCOME;
|
EID: 0033206759
PISSN: 15233812
EISSN: None
Source Type: Journal
DOI: 10.1007/s11920-999-0007-z Document Type: Review |
Times cited : (41)
|
References (52)
|